News and Trends 11 Oct 2022 Late-breaking data shows significant remission in children with EoE …presented which found higher dose Dupixent led to a 3.09 percentile increase in body weight for age percentile from baseline, compared to 0.29 for placebo. Adverse events Safety results were… October 11, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Nov 2024 Six exosome therapy companies driving development in the field …toxicities or serious adverse events at any dose level reported ILIAS Biologics specializes in developing engineered exosomes by loading large therapeutic payloads inside exosomes via its proprietary platform technology, EXPLOR…. November 12, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Oct 2024 GPCR therapies: Eight promising biotechs hacking the cell signaling pathway …safety study found that EP262 adverse events were all mild, lower than placebo, and did not get worse with an increase in dosage in patients with chronic urticaria and atopic… October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jul 2022 SOTIO Biotech starts solid tumor trial …promising cytokine in oncology, but IL-15-based approaches to date have fallen short of realizing this promise due to aberrant targeting and adverse events. SOT101 in combination with KEYTRUDA has shown… July 27, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 18 Jan 2023 Innovation in life sciences requires collaboration and community …proximity, coffee breaks and social events. It is natural to work next to an expert from another organisation, striking impromptu meetings and discussions which can lead almost anywhere. Open workspaces… January 18, 2023 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 3 Nov 2022 What’s on the horizon for gene editing-based therapies? …with each other at events and share how they can overcome these issues. Another key point was that the field is so early-stage that gene editing companies must stay in… November 3, 2022 - 8 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jan 2023 Watch: Addressing IP with Starting Bloch …company also assists companies addressing fundraising, as well as helping with management and tech transfer. Patman gives companies a calendar of events to address issues as they arise. The platform… January 1, 2023 - 1 minutemin - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2025 Is an HIV cure possible? The future of HIV therapy …events. However, the impact on the virus was more limited. All participants who paused antiretroviral therapy experienced viral rebound, although one individual maintained viral suppression for 16 weeks, compared to… July 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Inside Labiotech 28 Oct 2016 Santé, Labiotech.eu is now 2 years old! (and what a journey so far) …we started from a blank sheet and had to build everything (branding, concept, pricing, location, program…) from scratch. And it’s amazingly complicated just to get an event started! Organizing events… October 28, 2016 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 3 May 2023 Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline …of daily living such as managing finances, driving, engaging in hobbies, and conversing about current events. All secondary endpoints of cognitive and functional decline were also met and showed highly… May 3, 2023 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Dec 2017 Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017 …widespread clotting and organ damage. Caplacizumab significantly reduced the time to platelet count response and achieved a 74% reduction in the relative risk of thromboembolic events and death and a… December 18, 2017 - 9 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 17 Jan 2024 Bladder cancer treatment: where are we standing? …patients experienced grade ≥3 adverse events which refers to severe and significant medical events. In this case, the most common adverse event observed were ash maculo-papular, hyperglycemia, neutropenia, peripheral sensory… January 17, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email